Clearmind Medicine Inc. (NASDAQ:CMND) Sees Significant Growth in Short Interest

Clearmind Medicine Inc. (NASDAQ:CMND) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 620,700 shares, a growth of 453.7% from the December 31st total of 112,100 shares. Based on an average daily volume of 1,140,000 shares, the short-interest ratio is presently 0.5 days. Currently, 21.0% of the company’s stock are sold short.

Clearmind Medicine Price Performance

CMND stock opened at $1.37 on Wednesday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.01. Clearmind Medicine has a fifty-two week low of $0.95 and a fifty-two week high of $2.30. The stock’s 50 day simple moving average is $1.41 and its 200 day simple moving average is $1.40.

Clearmind Medicine (NASDAQ:CMND) last posted its earnings results on Wednesday, January 22nd. The company reported ($0.11) earnings per share for the quarter.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.